View drug registration information details.
| Items | Registration information |
|---|
| ID | 2113 |
|---|
| No | 2113 |
|---|
| Brand Name | STEI |
|---|
| Ingredients | BETAHISTINE DIHYDROCHLORIDE 8 MG. |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-PVC BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS AFTER MANUFACTURING DATE |
|---|
| Pack Size | BOX OF 10 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | VERTIGO,TINNITUS OR HEARING LOSS ASSOCIATED WITH MENIERE'S DISEASE.SYMPTOMATIC TREATMENT OF VESTIBULAR VERTIGO. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE ROUND TABLET EMBOSSED WITH '' SPS'', ''S11'' AND BREAKLINE ON ONE SIDE AND EMBOSSED WITH “S” ON THE OTHER SIDE. |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | SRIPRASIT PHARMA CO., LTD |
|---|
| Country | THAILAND |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 02 I 3835/13 |
|---|
| FDD Registration Date | 19-MAY-2023 |
|---|
| Expiry Date | 18-MAY-2026 |
|---|
Back to drug list
|
